When launching a new drug, pharma companies often focus on tangible targets like awareness, message recall or number of sales rep interactions and time spent with physicians. However, when it comes to prescribing a new drug, healthcare providers (HCPs) are more likely to do so if they trust the sales rep and if the message delivered is clear and unique, according to a recent HCP survey and whitepaper from ZoomRx.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters